Request appointment
160 East 53rd StreetNew York, NY 10022
Overview of Dr. Smithy
Dr. James Smithy is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Yale School of Medicine and has been in practice 9 years. He is one of 537 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 40 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
Mass General Brigham/Brigham and Women's HospitalChief Residency, Internal Medicine, 2021 - 2022
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2017 - 2020
Yale School of MedicineClass of 2017
Certifications & Licensure
FL State Medical License 2023 - Present
MA State Medical License 2017 - 2028
CT State Medical License 2023 - 2027
NJ State Medical License 2023 - 2027
NY State Medical License 2023 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- An anti-PMEL antibody-drug conjugate with a Ginhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.Matteo S Carlino, Ellen Kapiteijn, Sophie Piperno-Neumann, Ryan J Sullivan, Richard Carvajal
Nature Medicine. 2026-09-01 - Real-World, Evidence-Based, Retrospective Study of Patients Infused with Commercially Released Lifileucel for Advanced Melanoma.Lilit Karapetyan, Justin Moser, Barbara T Ma, Christopher Otteni, Elizabeth Cathcart
Transplantation and Cellular Therapy. 2026-09-01 - Outpatient Treatment-Related Toxicity After Hospital Discharge Among Patients Receiving Lifileucel for Advanced Melanoma.Mia Andreoli, Hannah L Kalvin, Elizabeth R Cathcart, Erin Walicki, Allison S Betof
JCO Oncology Practice. 2026-08-25
Press Mentions
Guideline: How to Adjust Cancer Therapy in Derm Surgery PatientsAugust 4th, 2026
Professional Memberships
- American Society of Clinical OncologyMember
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:






